SuperworthPenumbra profit margin PEN
Gross, operating and net profit as a share of revenue over the last twelve months, from 2014.
- Net margin, 12 months
- 10.7%
- Operating margin, 12 months
- 12.4%
- Net margin on a year earlier
- −0.9 pts
- Peer median
- 12.9%
Over the twelve months to Jun 30, 2026, Penumbra kept 10.7% of its revenue as net profit, with an operating margin of 12.4% and a gross margin of 67.8%.
Five years earlier its net margin was 2.4%.
The median for 10 medical instruments and supplies stocks of a similar size is 12.9%.
Profit margin over time
Fiscal year by fiscal year
| Fiscal year | Net margin | Operating margin | Gross margin |
|---|---|---|---|
| FY2025 | 12.7% | 13.5% | 67.1% |
| FY2024 | 1.2% | 0.8% | 63.2% |
| FY2023 | 8.6% | 6.9% | 64.5% |
| FY2022 | −0.2% | 0.7% | 63.2% |
| FY2021 | 0.7% | −1.0% | 63.6% |
| FY2020 | −2.8% | −6.9% | 60.3% |
| FY2019 | 8.9% | 8.7% | 68.0% |
| FY2018 | 1.5% | −0.2% | 65.7% |
| FY2017 | 1.4% | 0.3% | 65.1% |
| FY2016 | 5.6% | −0.5% | 64.9% |
| FY2015 | 1.3% | 2.2% | 66.7% |
| FY2014 | 1.8% | n/a | 66.0% |
Quarter by quarter
| Quarter | Ended | Net margin, 12 months | Change on a year | Operating margin |
|---|---|---|---|---|
| Q2 FY26 | 10.7% | −0.9 pts | 12.4% | |
| Q1 FY26 | 11.8% | +8.4 pts | 12.9% | |
| Q4 FY25 | 12.7% | +11.5 pts | 13.5% | |
| Q3 FY25 | 12.3% | +9.3 pts | 13.0% | |
| Q2 FY25 | 11.5% | +10.3 pts | 12.4% | |
| Q1 FY25 | 3.4% | −5.1 pts | 3.0% | |
| Q4 FY24 | 1.2% | −7.4 pts | 0.8% | |
| Q3 FY24 | 3.0% | −1.1 pts | 0.1% | |
| Q2 FY24 | 1.3% | −1.9 pts | −1.9% | |
| Q1 FY24 | 8.5% | +7.8 pts | 7.1% | |
| Q4 FY23 | 8.6% | +8.8 pts | 6.9% | |
| Q3 FY23 | 4.1% | +7.8 pts | 4.4% |
Against its peers
Companies in Medical - Instruments & Supplies nearest Penumbra's size, closest first, today.
| Company | Profit margin |
|---|---|
| PENPenumbra | 10.7% |
| COOCooper Companies | 13.5% |
| SOLVSolventum | 17.3% |
| ALGNAlign Technology | 10.0% |
| GMEDGlobus Medical | 17.0% |
| PODDInsulet | 12.3% |
| MSAMSA Safety | 16.1% |
| WSTWest Pharmaceutical Services | 17.0% |
| MMSIMerit Medical Systems | 9.2% |
| HAEHaemonetics | 7.1% |
| VNTVontier | 11.3% |
| Peer median | 12.9% |
Where Penumbra ranks
What the profit margin tells you
Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).
Compare within an industry. 10% is superb for a retailer and poor for a software company.
More on Penumbra
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.